Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, R. W.
Right arrow Articles by Malarkey, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, R. W.
Right arrow Articles by Malarkey, W. B.
NEUROLOGY 1979;29:855
© 1979 American Academy of Neurology

Disordered growth hormone and prolactin secretion in primary disorders of sleep

Robert W. Clark, M.D., Helmut S. Schmidt, M.D. and William B. Malarkey, M.D.

Division of Neurology, Department of Psychiatry, and Division of Endocrinology and Metabolism, The Ohio State University, Columbus, Ohio.

Growth hormone (GH) and prolactin (PRL) secretion were evaluated in 28 patients who had sleep apnea or narcolepsy but no other primary neurologic or endocrine disorders. Eighty-one percent of subjects with impaired alertness failed to demonstrate serum GH concentrations in excess of 5 ng per milliliter following oral administration of L-DOPA, 500 mg. Diminished GH responses to sleep and intravenous arginine were observed in 57 percent and 44 percent, respectively, of patients tested. Sleep-related PRL release was less than normal in women with narcolepsy, with or without sleep apnea. All patients had at least one abnormality in GH or PRL secretion.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Haqq, D. D. Stadler, R. H. Jackson, R. G. Rosenfeld, J. Q. Purnell, and S. H. LaFranchi
Effects of Growth Hormone on Pulmonary Function, Sleep Quality, Behavior, Cognition, Growth Velocity, Body Composition, and Resting Energy Expenditure in Prader-Willi Syndrome
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2206 - 2212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Overeem, S. W. Kok, G. J. Lammers, A. A. Vein, M. Frolich, A. E. Meinders, F. Roelfsema, and H. Pijl
Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E641 - E647.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Gianotti, S. Pivetti, F. Lanfranco, F. Tassone, F. Navone, E. Vittori, R. Rossetto, C. Gauna, S. Destefanis, S. Grottoli, et al.
Concomitant Impairment of Growth Hormone Secretion and Peripheral Sensitivity in Obese Patients with Obstructive Sleep Apnea Syndrome
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5052 - 5057.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by AAN Enterprises, Inc.